Bank of America
EBS icon

Bank of America’s Emergent Biosolutions EBS Stock Holding History

Bank of America’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,400
Closed -$592K – 8166
2021
Q2 		$592K Buy
+9,400
New +$604K ﹤0.01% 5287

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America's EBS Position: Q1 2026 in Review

Bank of America increased its Emergent Biosolutions (EBS) stake by 25% in Q1 2026, buying an estimated $378K and bringing the position to 183,443 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #4279.

Bank of America first reported a position in EBS in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q1 2021. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Bank of America held 183,443 shares of Emergent Biosolutions worth $1.52M as of Q1 2026.
  • Bank of America bought 36,499 Emergent Biosolutions shares in Q1 2026, an estimated $378K.
  • Emergent Biosolutions made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4279 holding.
  • Bank of America first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Emergent Biosolutions position peaked at $30.8M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.